- -------------------------
OMB APPROVAL
- -------------------------
- -------------------------
OMB Number: 3235-0145
Expires: December 31, 1997
Estimated average burden
hours per form 14.90
- --------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Amendment No. 1
to
SCHEDULE 13D
Under the Securities Exchange Act of 1934*
Chrysalis International Corporation
- ---------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $.01 par value per share
- ---------------------------------------------------------------------------
(Title of Class of Securities)
171188 10 5
-----------------------------------
(CUSIP Number)
Ray A. Mantle, Esq.
Piper & Marbury L.L.P.
1251 Avenue of the Americas
New York, New York 10020-1104
(212) 835-6180
- ---------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to Receive Notices and
Communications)
December 18, 1996
--------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition which is the subject of this Schedule 13D, and is
filing this schedule because of Rule 13d-1(b)(3) or (4), check the
following box |_|.
Check the following box if a fee is being paid with the statement |_|. (A
fee is not required only if the reporting person: (1) has a previous
statement on file reporting beneficial ownership of more than five percent
of the class of securities described in Item 1; and (2) has filed no
amendment subsequent thereto reporting beneficial ownership of five
percent or less of such class.) (See Rule 13d-7.)
Note: Six copies of this statement, including all exhibits, should be
filed with the Commission. See Rule 13d-1(a) for other parties to whom
copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of
the Act (however, see the Notes).
Page 1 of 7
<PAGE>
CUSIP No. 171188 10 5 Schedule 13D
- ---------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Mr. Alec Hackel
- ---------------------------------------------------------------------------
- ---------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |X|
(b) |_|
- ---------------------------------------------------------------------------
- ---------------------------------------------------------------------------
3 SEC USE ONLY
- ---------------------------------------------------------------------------
- ---------------------------------------------------------------------------
4 SOURCE OF FUNDS
PF
- ---------------------------------------------------------------------------
- ---------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d) or 2(e) |_|
- ---------------------------------------------------------------------------
- ---------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Switzerland
- ---------------------------------------------------------------------------
--------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 955,293.3
--------------------------------------------------------------
--------------------------------------------------------------
SHARES 8 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 2,647,448
--------------------------------------------------------------
--------------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON 955,293.3
--------------------------------------------------------------
--------------------------------------------------------------
WITH 10 SHARED DISPOSITIVE POWER
2,647,448
--------------------------------------------------------------
- ---------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,647,448
- ---------------------------------------------------------------------------
- ---------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
|_|
- ---------------------------------------------------------------------------
- ---------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
23.3%
- ---------------------------------------------------------------------------
- ---------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IN
- ---------------------------------------------------------------------------
Page 2 of 7
<PAGE>
CUSIP No. 171188 10 5 Schedule 13D
- ---------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Dr. Jack Barbut
- ---------------------------------------------------------------------------
- ---------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |X|
(b) |_|
- ---------------------------------------------------------------------------
- ---------------------------------------------------------------------------
3 SEC USE ONLY
- ---------------------------------------------------------------------------
- ---------------------------------------------------------------------------
4 SOURCE OF FUNDS
PF
- ---------------------------------------------------------------------------
- ---------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d) or 2(e) |_|
- ---------------------------------------------------------------------------
- ---------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Switzerland
- ---------------------------------------------------------------------------
--------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 1,005,293.3
--------------------------------------------------------------
--------------------------------------------------------------
SHARES 8 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 2,647,448
--------------------------------------------------------------
--------------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON 1,005,293.3
--------------------------------------------------------------
--------------------------------------------------------------
WITH 10 SHARED DISPOSITIVE POWER
2,647,448
--------------------------------------------------------------
- ---------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,647,448
- ---------------------------------------------------------------------------
- ---------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
|_|
- ---------------------------------------------------------------------------
- ---------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
23.3%
- ---------------------------------------------------------------------------
- ---------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IN
- ---------------------------------------------------------------------------
Page 3 of 7
<PAGE>
CUSIP No. 171188 10 5 Schedule
13D
- ---------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Dr. John Christian Jensen
- ---------------------------------------------------------------------------
- ---------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |X|
(b) |_|
- ---------------------------------------------------------------------------
- ---------------------------------------------------------------------------
3 SEC USE ONLY
- ---------------------------------------------------------------------------
- ---------------------------------------------------------------------------
4 SOURCE OF FUNDS
PF
- ---------------------------------------------------------------------------
- ---------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d) or 2(e) |_|
- ---------------------------------------------------------------------------
- ---------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
The United States of America
- ---------------------------------------------------------------------------
--------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 686,861.5
--------------------------------------------------------------
--------------------------------------------------------------
SHARES 8 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 2,647,448
--------------------------------------------------------------
--------------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON 686,861.5
--------------------------------------------------------------
--------------------------------------------------------------
WITH 10 SHARED DISPOSITIVE POWER
2,647,448
--------------------------------------------------------------
- ---------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,647,448
- ---------------------------------------------------------------------------
- ---------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
|_|
- ---------------------------------------------------------------------------
- ---------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
23.3%
- ---------------------------------------------------------------------------
- ---------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IN
- ---------------------------------------------------------------------------
Page 4 of 7
<PAGE>
Item 3. Source and Amount of Funds or Other Consideration.
Stock options for 50,000 shares of Chrysalis' Common Stock
each were granted to Dr. Barbut and Dr. Jensen effective as
of December 18, 1996 pursuant to Chrysalis' Incentive Stock
Option Plan ("ISO Plan") and the employment agreements of
Dr. Barbut and Dr. Jensen. The stock options have a term of
10 years expiring December 18, 2006 and an exercise price of
$5.0625 per share. The options vest at the rate of 25% per
year upon the grant anniversary date.
Item 4. Purposes of Transaction.
The stock options granted to Dr. Barbut and Dr. Jensen under
Chrysalis' ISO Plan were pursuant to the terms of their
employment agreements and Chrysalis' policy regarding the
use of stock options as part of executive compensation
packages for key personnel.
Item 5. Interest in Securities of the Issuer.
Mr. Hackel
(a) Amount Beneficially Owned
2,647,448
Percent of Class 23.3%
(b) Number of shares as to which such person has:
(i) sole power to vote or direct the vote 955,293.3
(ii) shared power to vote or direct the vote
2,647,448
(iii)sole power to dispose or to direct the
disposition of 955,293.3
(iv) shared power to dispose or to direct the
disposition of 2,647,448
Dr. Barbut
(a) Amount Beneficially Owned 2,647,448
Percent of Class 23.3%
(b) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote 1,005,293.3
(ii) shared power to vote or to direct the vote 2,647,448
(iii)sole power to dispose or to direct the
disposition of 1,005,293.3
(iv) shared power to dispose or to direct
the disposition of 2,647,448
Page 5 of 7
<PAGE>
Dr. Jensen
(a) Amount Beneficially Owned 2,647,448
Percent of Class 23.3%
(b) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote 686,861.5
(ii) shared power to vote or to direct the
vote 2,647,448
(iii)sole power to dispose or to direct the
disposition of 686,861.5
(iv) shared power to dispose or to direct
the disposition of 2,647,448
(c) Not applicable.
(d) No person except for Messrs. Hackel, Barbut
and Jensen,
is known to have a right to receive or the power to
direct the receipt of dividends from, or the proceeds
from the sale of, the Chrysalis Common Stock owned by
Messrs. Hackel, Barbut and Jensen.
(e) Not applicable.
(f) Citizenship
Mr. Hackel is a citizen of Switzerland, Dr. Barbut is a
citizen of Switzerland resident in the United States of
America and Dr. Jensen is a citizen of the United
States of America resident in Switzerland.
Item 7. Material to be Filed as Exhibits.
None.
Page 6 of 7
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is
true, complete and correct.
Date: April 21, 1997 MR. ALEC HACKEL
By: /s/ Ray A. Mantle, Esq.
Attorney-in-Fact
Date: April 21, 1997 DR. JACK BARBUT
By: /s/Ray A. Mantle, Esq.
Attorney-in-Fact
Date: April 21, 1997 DR. JOHN CHRISTIAN JENSEN
By: /s/Ray A. Mantle, Esq.
Attorney-in-Fact
Page 7 of 7
<PAGE>
